Sintx Technologies (SINT) Restructuring Costs (2024)
Sintx Technologies (SINT) posted quarterly Restructuring Costs of -$4.1 million for Q4 2024, down 191.03% quarter-over-quarter from $4.5 million in Q3 2024.
Sintx Technologies (SINT) Restructuring Costs (2024) Analysis & Trends
Sintx Technologies' Restructuring Costs history runs 1 years deep, the most recent figure standing at -$4.1 million for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Sintx Technologies | 7.61 Mn | 7.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4.06 Mn |
| Sep 30, 2024 | 4.46 Mn |